Skip to main content
Fig. 1 | Molecular Medicine

Fig. 1

From: Prognostic value of kallikrein-related peptidase 12 (KLK12) mRNA expression in triple-negative breast cancer patients

Fig. 1

Overall survival (OS) and disease-free survival (DFS) of patients with triple-negative breast cancer according to KLK12 mRNA expression in primary tumor tissues. Patients with positive KLK12 mRNA expression had a significantly shortened OS (a) and DFS (b) than those with negative KLK12 mRNA expression (p = 0.033 and p = 0.009, respectively). Survival curves were drawn according to the Kaplan-Meier survival analysis. P values were calculated via the log-rank algorithm

Back to article page